Should I Buy INBS? INBS 2026 Analysis

Should You Buy Intelligent Bio Solutions Inc (INBS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

8.860

1 Day change

-2.53%

52 Week Range

27.500

Analysis Updated At

2026/01/26

Intelligent Bio Solutions Inc (INBS) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows no significant positive momentum, lacks strong trading signals, and has weak financial performance with declining EPS and negative net income. The absence of recent news, congress trading data, and analyst ratings further limits the clarity of its potential as a long-term investment.

Technical Analysis

The technical indicators for INBS suggest a bearish trend. The MACD is negatively expanding, RSI is neutral at 31.41, and moving averages are converging, indicating no clear direction. The stock is trading near its support level (S1: 9.698), but the overall trend lacks positive momentum.

Options Data

Positive Catalysts

2026/01/26 01:19:33

Revenue increased by 27.46% YoY in Q1 2026, and gross margin improved significantly by 263.35% YoY.

Neutral/Negative Catalysts

2026/01/26 01:19:33

No recent news, congress trading data, or analyst ratings are available. Stock trend analysis shows a higher probability of negative returns in the short term.

Financial Performance

In Q1 2026, revenue increased by 27.46% YoY to $1,111,797, and gross margin improved to 19.33%. However, net income remains negative at -$2,983,006 (up 11.07% YoY), and EPS dropped significantly by 50.50% YoY to -3.49.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available for INBS.

Analyst Rating

Wall Street analysts forecast INBS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INBS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 9.090

Low

Averages

High